CU in the News

Chula Wins! Thai Nationality for COVID Vaccine Registration after the Virus Extraction Was Found to Be Higher than the mRNA Used Today

Chulalongkorn wins! Thai nationality for COVID vaccine registration

4 May 2022 – Prof. Dr. Kiat Rakrungtham Executive Director of the COVID-19 Vaccine Development Project Vaccine Research Center Faculty of Medicine Chulalongkorn and Chulalongkorn Hospital (Hospital), Thai Red Cross Society gave an interview about the development progress. Covid-19 vaccine or ChulaCov19 which is a Thai national vaccine type mRNA. The overall development of the ChulaCov19 vaccine is good news. The development is divided into 2 phases: first stage which let the factory in the United States produce the first lot The good news is that it has been proven in Phase 1 and Phase 2 volunteers. It was found that it was safe and highly stimulating the immune system.

“And the size we chose compared to the vaccine approved for use in Thailand, such as Pfizer, was clearly higher in our immunity,” said Prof. Dr. Kiat. second phase is the production of vaccines in the country The factory in Thailand is Bionet Asia. was able to produce the first batch of vaccines in Thailand already passed quality assurance The research team then submitted various documents and information to the Food and Drug Administration (FDA) asking the Food and Drug Administration to approve the trials in phase 1 and phase 2.

Prof. Dr. Kiat said that the matter is currently pending approval from FDA to start testing in volunteers It is expected that the answer will be received soon if the test can be achieved according to the goals set. It is expected that vaccine registration can be requested by the end of 2022.

“The epidemic situation in the country is getting better and better. But the research team’s vaccine development didn’t stop. We would like to see the first generation of vaccines produced by Thai people who are now developing 3 types, namely Chulalongkorn University’s vaccine, leaflet vaccine, and the Government Pharmaceutical Organization (GPO) vaccine, can be registered at least 1 type first or can All will be better. The first batch of vaccines, according to the procedure, should be registered first. Must be proven to be safe While requesting for the registration of the first generation vaccine, we are also developing the second generation vaccine to protect against omikron at the same time. to wait for registration in the next order Importantly, Thailand has our own technology. From the invention, design, testing and production in the factory in the country enabling us to be self-reliant If there is a new outbreak of Covid-19, no matter what species Or a new disease outbreak occurs, we will be able to develop a vaccine by ourselves in a faster time. because we can develop the whole chain by ourselves,” said Prof. Dr. Kiat.

Prof. Dr. Kiat said that if Thai vaccines can be registered within this year must rely on all sectors to support each other But vaccine production has to be done step by step. Both have to prove their effectiveness and safety. which is the main objective of Thailand’s vaccine development so that we can be self-reliant as well as helping to distribute vaccines to neighboring countries faster If an epidemic occurs And the fact that we have technology from upstream, midstream to downstream, when an epidemic occurs will do faster The process of inventing, designing, manufacturing and testing in humans, Phase 1 and Phase 2, within no more than 6 months, not over a year. as it is currently operating. because at that time the chain was not yet complete

Source: News Directory3

Chula’s encouragement and support for research is excellent for teachers, students, and the public.

Associate Professor Dr. Suchana Chavanich Faculty of Science, Chulalongkorn University

This website uses cookies to personalize content, provide the best user experience, and improve Chula website services.

Privacy Preferences

ท่านสามารถเลือกการตั้งค่าคุกกี้โดยเปิด/ปิด คุกกี้ในแต่ละประเภทได้ตามความต้องการ ยกเว้น คุกกี้ที่จำเป็น

Accept All
Manage Consent Preferences
  • คุกกี้ที่จำเป็น
    Always Active

    ประเภทของคุกกี้ที่มีความจำเป็นสำหรับการทำงานของเว็บไซต์ เพื่อให้คุณสามารถใช้เว็บไซต์ได้อย่างเป็นปกติ ท่านไม่สามารถปิดการทำงานของคุกกี้นี้ในระบบเว็บไซต์ของเราได้

  • คุกกี้เพื่อการวิเคราะห์

    คุกกี้ประเภทนี้จะทำการเก็บข้อมูลพฤติกรรมการใช้งานเว็บไซต์ของคุณ โดยมีจุดประสงค์คือนำข้อมูลมาวิเคราะห์เพื่อปรับปรุงและพัฒนาเว็บไซต์ให้มีคุณภาพ และสร้างประสบการณ์ที่ดีกับผู้ใช้งาน เพื่อให้เกิดประโยชน์สูงสุด หากท่านไม่ยินยอมให้เราใช้คุกกี้นี้ เราอาจไม่สามารถวัดผลเพื่อการปรับปรุงและพัฒนาเว็บไซต์ให้ดีขึ้นได้
    Cookies Details